Overview

A Prospective Randomized Comparison Trial on the Use of Mifepristone With Sublingual or Buccal Misoprostol for Medical Abortions of Less Than 9 Weeks Gestation

Status:
Completed

Trial end date:
2011-08-01

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to compare the incidence of side effects of buccal and sublingual misoprostol when combined with mifepristone for medical abortions of less than 9 weeks gestation. The secondary outcome is to compare the complete abortion rate and induction-abortion interval between the two methods of administration of misoprostol.

Phase:

Phase 4

Details

Lead Sponsor:

The University of Hong Kong

Treatments:

Mifepristone
Misoprostol